Cargando…
Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
Blood‐based biomarkers are gaining interest for response evaluation in classical Hodgkin lymphoma (cHL). However, it is unknown how blood‐based biomarkers relate to quantitative (18)F‐FDG‐PET features. We correlated extracellular vesicle‐associated miRNAs (EV‐miRNA), serum TARC, and complete blood c...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422001/ https://www.ncbi.nlm.nih.gov/pubmed/36051072 http://dx.doi.org/10.1002/jha2.432 |
_version_ | 1784777721376669696 |
---|---|
author | Drees, Esther E. E. Driessen, Julia Zwezerijnen, Gerben J. C. Verkuijlen, Sandra A. W. M. Eertink, Jakoba J. van Eijndhoven, Monique A. J. Groenewegen, Nils J. Vallés‐Martí, Andrea de Jong, Daphne Boellaard, Ronald de Vet, Henrica C. W. Pegtel, Dirk M. Zijlstra, Josée M. |
author_facet | Drees, Esther E. E. Driessen, Julia Zwezerijnen, Gerben J. C. Verkuijlen, Sandra A. W. M. Eertink, Jakoba J. van Eijndhoven, Monique A. J. Groenewegen, Nils J. Vallés‐Martí, Andrea de Jong, Daphne Boellaard, Ronald de Vet, Henrica C. W. Pegtel, Dirk M. Zijlstra, Josée M. |
author_sort | Drees, Esther E. E. |
collection | PubMed |
description | Blood‐based biomarkers are gaining interest for response evaluation in classical Hodgkin lymphoma (cHL). However, it is unknown how blood‐based biomarkers relate to quantitative (18)F‐FDG‐PET features. We correlated extracellular vesicle‐associated miRNAs (EV‐miRNA), serum TARC, and complete blood count (CBC) with PET features (e.g., metabolic tumor volume [MTV], dissemination and intensity features) in 30 cHL patients at baseline. EV‐miR127‐3p, EV‐miR24‐3p, sTARC, and several CBC parameters showed weak to strong correlations with MTV and dissemination features, but not with intensity features. Two other EV‐miRNAs only showed weak correlations with PET features. Therefore, blood‐based biomarkers may be complementary to PET features, which warrants further exploration of combining these biomarkers in prognostic models. |
format | Online Article Text |
id | pubmed-9422001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94220012022-08-31 Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma Drees, Esther E. E. Driessen, Julia Zwezerijnen, Gerben J. C. Verkuijlen, Sandra A. W. M. Eertink, Jakoba J. van Eijndhoven, Monique A. J. Groenewegen, Nils J. Vallés‐Martí, Andrea de Jong, Daphne Boellaard, Ronald de Vet, Henrica C. W. Pegtel, Dirk M. Zijlstra, Josée M. EJHaem Short Reports Blood‐based biomarkers are gaining interest for response evaluation in classical Hodgkin lymphoma (cHL). However, it is unknown how blood‐based biomarkers relate to quantitative (18)F‐FDG‐PET features. We correlated extracellular vesicle‐associated miRNAs (EV‐miRNA), serum TARC, and complete blood count (CBC) with PET features (e.g., metabolic tumor volume [MTV], dissemination and intensity features) in 30 cHL patients at baseline. EV‐miR127‐3p, EV‐miR24‐3p, sTARC, and several CBC parameters showed weak to strong correlations with MTV and dissemination features, but not with intensity features. Two other EV‐miRNAs only showed weak correlations with PET features. Therefore, blood‐based biomarkers may be complementary to PET features, which warrants further exploration of combining these biomarkers in prognostic models. John Wiley and Sons Inc. 2022-04-28 /pmc/articles/PMC9422001/ /pubmed/36051072 http://dx.doi.org/10.1002/jha2.432 Text en © 2022 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Reports Drees, Esther E. E. Driessen, Julia Zwezerijnen, Gerben J. C. Verkuijlen, Sandra A. W. M. Eertink, Jakoba J. van Eijndhoven, Monique A. J. Groenewegen, Nils J. Vallés‐Martí, Andrea de Jong, Daphne Boellaard, Ronald de Vet, Henrica C. W. Pegtel, Dirk M. Zijlstra, Josée M. Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma |
title | Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma |
title_full | Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma |
title_fullStr | Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma |
title_full_unstemmed | Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma |
title_short | Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma |
title_sort | blood‐circulating ev‐mirnas, serum tarc, and quantitative fdg‐pet features in classical hodgkin lymphoma |
topic | Short Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422001/ https://www.ncbi.nlm.nih.gov/pubmed/36051072 http://dx.doi.org/10.1002/jha2.432 |
work_keys_str_mv | AT dreesestheree bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma AT driessenjulia bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma AT zwezerijnengerbenjc bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma AT verkuijlensandraawm bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma AT eertinkjakobaj bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma AT vaneijndhovenmoniqueaj bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma AT groenewegennilsj bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma AT vallesmartiandrea bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma AT dejongdaphne bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma AT boellaardronald bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma AT devethenricacw bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma AT pegteldirkm bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma AT zijlstrajoseem bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma |